Herein, we report a protein-based hybridization strategy that exploits the host-guest chemistry of HSA (human serum albumin) to solubilize the otherwise cell impermeable ONOO À fluorescent probe Pinkment-OAc. Formation of a HSA/Pinkment-OAc supramolecular hybrid was confirmed by SAXS and solution-state analyses. This HSA/Pinkment-OAc hybrid provided an enhanced fluorescence response towards ONOO À versus Pinkment-OAc alone, as determined by in vitro experiments. The HSA/ Pinkment-OAc hybrid was also evaluated in RAW 264.7 macrophages and HeLa cancer cell lines, which displayed an enhanced cell permeability enabling the detection of SIN-1 and LPS generated ONOO À and the in vivo imaging of acute inflammation in LPS-treated mice. A remarkable 5.6 fold (RAW 264.7), 8.7fold (HeLa) and 2.7-fold increased response was seen relative to Pinkment-OAc alone at the cellular level and in vivo, respectively. We anticipate that HSA/fluorescent probe hybrids will soon become ubiquitous and routinely applied to overcome solubility issues associated with hydrophobic fluorescent imaging agents designed to detect disease related biomarkers.
Introduction
Biochemical processes involve complex interactions between cellular components. Signalling molecules such as reactive oxygen species and reactive nitrogen species (ROS/RNS) play a crucial role in mediating these interactions and are required to maintain proper cell function. ROS/RNS consist of oxidative oxygen and nitrogen-based ions or free radicals. 1, 2 The overexpression of ROS/RNS has been implicated in an array of diseases, including cancer, inammatory diseases, and CNS neurodegeneration. 3, 4 The widespread interest in biochemical processes where ROS/RNS play key roles, as well as deviations from homeostasis associated with various disease states, has provided an inspiration to develop probes that allow for the facile detection of these species. Fluorescence-based probes have received considerable attention in recent years in the context of ROS/RNS sensing. Ground-up synthetic methods have, for instance, allowed for the incorporation of reactive functionalities within the uorophore scaffolds used to create such probes. [5] [6] [7] [8] [9] These modications have conferred utility for the detection and visualization of aberrant ROS/RNS levels considered causal in certain diseases. [6] [7] [8] Despite signicant progress, a number of issues remain to be addressed in the area of ROS/RNS probe design. In particular, standard uorescent probes are oen hydrophobic leading to poor cell permeability and aggregation induced quenching (ACQ). 10 To overcome these limitations, a number of supramolecular-based strategies have been developed. [11] [12] [13] [14] [15] [16] [17] Complementary to these efforts, researchers have utilized protein-based hybridization strategies (host-guest assembly) as a means to overcome the poor solubility and enhance the imaging capability of a contrast agent used in bioimaging applications. 18, 19, 39 We thus envisaged that judicious design of an appropriate uorescent probe-protein complex might permit enhanced sensitivity towards the detection of a disease-specic biomarker. Herein, we present the rst demonstration of a uorescent probe-protein complex strategy that results in the enhanced in vitro and in vivo detection of a key ROS/RNS signaling agent, in this case peroxynitrite (ONOO À ) -Scheme 1.
ONOO À is a RNS that is formed via the diffusion-controlled reaction between superoxide (O 2 c À ) and nitric oxide (NOc). ONOO À is characterized by its deleterious properties, causing irreversible damage to a range of biological targets. 40 Recent efforts have focused on the development of uorescent probes for the detection of ONOO À . [20] [21] [22] [23] [24] Towards this end, boronates have proven useful, allowing for a "turn-on" mechanism when incorporated within the sensing motif. The inherent reactivity of these substituents confers selectivity towards ONOO À over other ROS signaling molecules, such as hypochlorous acid (HOCl/ClO À ) and hydrogen peroxide (H 2 O 2 ). 25 Recently, we developed a series 'Pinkment' uorescent probes based on resorun. 26 We designed those 'Pinkment' probes to display 'AND'-logic in the presence of two different biologically important species. 26 In particular the Pinkment-OAc probe was designed to be activated by an esterase 'AND' H 2 O 2 but the probe exhibited poor solubility and low cell permeability limiting its biological applications. Our aim with this research was to develop a general strategy to improve the sensitivity, solubility and uptake capabilities of a poorly performing uorescent probe without changing its structure. Since, Pinkment-OAc could be selectively activated by ONOO À (via oxidation of the boronate and cleavage of the acetate ester -Scheme S1 †), it represented a good example of an underperforming probe, suitable for development as an ONOO À selective uorescent probe-protein hybrid with enhanced biological applicability.
Therefore, Pinkment-OAc was synthesized using the previously reported procedure. 26 Incorporation of Pinkment-OAc within HSA to give HSA/Pinkment-OAc was then achieved via sonication of a simple mixture of the probe and HSA in water. In addition, Pinkment-OH was synthesized as previously reported 26 and used to form a HSA/Pinkment-OH hybrid to illustrate the generality of our encapsulation strategy.
The sensitivity of these two probes towards ONOO À was then determined ( Fig. 1 ). Unsurprisingly, Pinkment-OAc ( Fig. 1A) and Pinkment-OH ( Fig. 1D ) gave rise to a dose dependent increase in uorescence intensity when exposed to ONOO À in PBS (phosphate buffered saline, pH 7.4) solution. The effect, however, is modest. In contrast, a much stronger response was seen for both HSA/Pinkment-OAc ( Fig. 1B) and HSA/Pinkment-OH ( Fig. 1E ). In the presence of ONOO À (10 mM), a 3-fold enhancement in uorescence intensity was observed for HSA/ Pinkment-OAc (Fig. 1C) whereas HSA/Pinkment-OH afforded a 2-fold increase in uorescence intensity ( Fig. 1F ) when compared to each probe alone. This was taken as an initial indication of the strong affinity of HSA for each Pinkment probe. In support of this, the binding constant (K a ) between Pinkment-OAc and HSA was measured through isothermal titration calorimetry with HSA (Fig. S1 †). As expected, strong binding between Pinkment-OAc and HSA was observed with a binding constant of K a ¼ 2.83 Â 10 5 L mol À1 . The quantum yield (F F ; relative to quinine sulfate (probe w/o ONOO À ) and rhodamine B (probe w/ ONOO À )) and extinction coefficient (3) of HSA/Pinkment-OAc before and aer addition of ONOO À were determined (Table S1 †). Subsequently, the pH-dependence of Pinkment-OAc and HSA/Pinkment-OAc to detect ONOO À was evaluated and compared. Remarkably, a greater ONOO À sensitivity was observed for HSA/Pinkment-OAc when compared to Pinkment-OAc alone over a wide pH range of 3-9 (in particular from pH 5-8) ( Fig. S2 †) .
In order to gain a greater understanding of the interactions between Pinkment-OAc and HSA, small-angle X-ray scattering (SAXS) measurements were carried out. SAXS is a powerful technique that enables conformational changes within biomacromolecules to be observed. 27, 28 The SAXS prole for homogeneous HSA and the HSA/Pinkment-OAc hybrid (w/w ¼ 1 : 10) is shown in Fig. 2A and E, respectively. To explore the conformational changes of the hybrid, SREFLEX, a hybrid modeling program that systematically combines SAXS data and normal mode analysis (NMA) was used to obtain threedimensional models of both HSA (Fig. 2B , middle) and the HSA/Pinkment-OAc hybrid (Fig. 2B, top) . 29 The threedimensional SAXS model of HSA and HSA/Pinkment-OAc hybrid were then superimposed onto a resolved HSA atomic structure (PDB entry: 1n5u, Fig. 2B, bottom) , respectively, using the program SUPCOMB. The modelling result obtained in this way revealed a signicant conformational change of the HSA/ Pinkment-OAc hybrid at the IIA region, and minimal change within the IIIA region with respect to the crystal structure of HSA ( Fig. 2C) . Conversely, the tting of the SAXS model of HSA alone with its crystal structure led to good consistency for both the IIA and IIIA regions ( Fig. 2G ).
We also compared the interatomic distance distribution function (P(r)) prole for both models (Fig. 2F) . The results were consistent with a slightly increased maximum diameter (D max ) for the HSA protein aer inclusion of Pinkment-OAc to produce HSA/Pinkment-OAc (76.4 to 79.3Å). The SAXS data thus provides support for the formation of a hybrid structure consisting of Pinkment-OAc and HSA. These data and the associated modeling also lead us to suggest that Pinkment-OAc is mainly bound to the IIA region of HSA. To complement the above studies, a competition assay was performed with a known IIA-region binder (phenylbutazone) and a known IIIA-region binder (ibuprofen). Satisfyingly, it was found that phenylbutazone was signicantly better at competitively interrupting the association between Pinkment-OAc and HSA compared to ibuprofen (Fig. S3 †) . This was taken as further evidence that inclusion of Pinkment-OAc within HSA occurs predominantly at the IIA region of the protein.
Molecular docking studies were then carried out with the goal of determining how Pinkment-OAc is bound within the IIA region of HSA. On the basis of these studies, we propose that Pinkment-OAc enters the hydrophobic cavity of the HSA subdomain IIA and is stabilized by a hydrophobic interaction with the amino acid residue, Leu481 (Fig. 2H, le) . Meanwhile, the carbonyl oxygen (OAc) and the oxygen on the phenoxazine unit are hydrogen bonded to Lys199 and Trp214, respectively. In addition, the benzene ring of Pinkment-OAc is involved in a pcation interaction with the nitrogen atom of the polar amino acid residue Lys199 and a p-p interaction with Phe211 ( Fig. 2H) . Taken in concert, these inferred interactions provide a rationale for the inference that Pinkment-OAc is tightly bound to HSA at the IIA domain. The modeling studies also revealed that the polar groups of resorun (the reaction product of Pinkment-OAc and ONOO À ) interact with several polar residues in the IIA domain of HSA. These polar groups include the carbonyl oxygen, phenolic unit, and nitrogen atom of the aromatic core, which stabilize hydrogen bonding interactions with the residues Lys199, Tyr148, and Arg257, respectively (Fig. 2H, right) . The resulting strong binding of resorun within the hydrophobic pocket of HSA would account for the enhanced uorescence seen when the HSA/Pinkment-OAc hybrid is exposed to ONOO À (Fig. 1) .
As noted above, hybridization between HSA and Pinkment-OAc leads to an enhanced uorescence response in the presence of ONOO À . We therefore sought to test whether the HSA/Pinkment-OAc hybrid could be used to image ONOO À in vitro and in vivo. Towards this end, a macrophage cell line (RAW 264.7) and a human cervical cancer cell line (HeLa) were treated with Pinkment-OAc and the HSA/Pinkment-OAc hybrid. Each cell line was then evaluated with or without SIN-1 (an exogenous agent known to upregulate intracellular ONOO À concentrations). 30 The cells were then visualized via confocal laserscanning microscopy (CLSM) (Fig. 3 ). As expected, in the absence of SIN-1, no uorescence was observed in either cell line; this was true for both free Pinkment-OAc and the HSA/ Pinkment-OAc hybrid. Subsequent treatment with SIN-1 led to a remarkable uorescence increase for HSA/Pinkment-OAc whereas a minimal uorescence response was observed for Pinkment-OAc alone. Specically, an overall 5.6-fold (RAW 264.7) and 8.7-fold (HeLa) difference in uorescence intensity between HSA/Pinkment-OAc and Pinkment-OAc was observed for these two cell lines ( Fig. 3B and C) . In order to compare the sensitivity of HSA/Pinkment-OAc to that of Pinkment-OAc alone, we used high-content microscopy to quantify the uorescence intensity of Pinkment-OAc and HSA/Pinkment-OAc in RAW 264.7 cells, both with and without treatment with SIN-1. As shown in Fig. S4 , † a 5.4-fold increase in integrated uorescence intensity for HSA/Pinkment-OAc was observed when treated with SIN-1 compared to Pinkment-OAc alone.
It has been reported that HSA can be actively endocytosed through clathrin-mediated pathway. 31 To demonstrate that these HSA/Pinkment probes underwent a similar clathrinmediated endocytosis, temperature-dependent uorescence imaging experiments were carried out. In addition, uorescence imaging experiments were carried out using a known clathrin inhibitor to inhibit clathrin-facilitated endocytosis. A decreased intracellular uorescence response was observed, when the temperature was decreased to 4 C (Fig. S5 †) , suggesting a kinetically controlled cell uptake process. Interestingly, the use of the known clathrin inhibitor chlorpromazine similarly led to a decreased uorescence response (Fig. S6 †) , which suggests that HSA/Pinkment-OAc underwent a clathrinmediated endocytosis to facilitate cellular uptake of Pinkment-OAc. Fluorescence co-localization experiments of HSA/ Pinkment-OAc with a lysosome tracker ( Fig. S7 †) (Pearson's correlation (R r ) ¼ 0.93), revealed that clathrin-mediated endocytosis resulted in accumulation of HSA/Pinkment-OAc in the lysosome of cells. This observation is in agreement with a previous report describing the lysosome-localization of HSAbased biomaterials. 32 To demonstrate that both probe and hybrid displayed minimal toxicity towards cells, an MTS assay was performed using a RAW 264.7 cell line. As expected, little change in the cell viability was observed upon increasing concentrations of HSA/ Pinkment-OAc from 5/5 mM to 80/80 mM (Fig. S8 †) . These ndings further support our suggestion that the HSA hybridization strategy reported here may represent a general and robust approach that could be used to enhance the intracellular sensitivity of small molecule probes in vitro without triggering an adverse cellular toxicity response.
The over-production of intracellular ONOO À is believed to contribute to the development of a wide variety of inammatory diseases. [33] [34] [35] Therefore, we turned our attention to testing whether HSA/Pinkment-OAc and Pinkment-OAc could be used to detect endogenous ONOO À in vitro and in vivo. To achieve the imaging of endogenous ONOO À in vitro, RAW 264.7 cells were treated with lipopolysaccharide (LPS), which is known to induce an inammatory response with acute upregulation of ONOO À . 36 As shown in Fig. 4 , a larger uorescence increase was observed for HSA/Pinkment-OAc compared to Pinkment-OAc alone (Fig. 4 ). This again suggests the benecial effect of the HSA encapsulation strategy for an increased cellular uptake of the probe and enhanced uorescence imaging of endogenously produced ONOO À .
Subsequently, an in vivo experiment was carried out by treating C57BL/6J mice with LPS. In this way, a mouse model for acute inammation was established according to the literature. 37, 38 The mice were divided into two groups; one was administered with pure saline intraperitoneally (i.p.) as a control, while the other was injected i.p. with LPS (200 mL, 2 mg mL À1 ) to induce acute inammation. Aer 4 h, the mice were anaesthetized, and their abdominal fur was removed. Next, the two groups of mice were treated (via i.p. injection) with DMSO (control), Pinkment-OAc, or HSA/Pinkment-OAc. Images were acquired using the IVIS spectrum imaging system. In the case of the LPS-treated and saline-treated mice, no uorescence was observed when injected with DMSO ( Fig. 5 ). However, the LPS-treated mice that were injected with HSA/Pinkment-OAc produced an approximately 2.7-fold greater increase in uorescence signal when compared to Pinkment-OAc alone ( Fig. 5A  and B ). These in vivo experiments provide support for the contention that the present HSA/Pinkment-OAc hybrid approach allows ONOO À production to be monitored effectively in vivo and with greater sensitivity than provided by the constituent probe (Pinkment-OAc).
Conclusions
In this work, we have demonstrated the viability of a simple protein-based hybridization strategy, that involves incorporation of an insoluble ONOO À uorescent probe (Pinkment-OAc) with HSA. The resulting HSA/Pinkment-OAc hybrid was characterized using SAXS analyses in conjunction with molecular docking studies. In solution, the HSA/Pinkment-OAc hybrid produced an enhanced uorescence response towards ONOO À compared to the Pinkment-OAc probe alone. More importantly, the HSA/Pinkment-OAc hybrid permitted improved ONOO À detection in RAW 264.7 and HeLa cells relative to the free Pinkment-OAc probe. This enhancement is ascribed to improved cell permeability. In addition, our hybrid strategy was effective for the in vivo imaging of acute inammation in LPStreated mice, where again an improved performance was seen compared to the probe alone. On the basis of the present ndings, we suggest that this approach represents a simple and general strategy to overcome the issues of low solubility and poor cell permeability that currently limit the use of hydrophobic imaging agents in vivo.
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